Lv5
1550 积分 2024-05-14 加入
A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide
3天前
已完结
Efficacy of Tonlamarsen in Patients with Uncontrolled Hypertension: The KARDINAL Phase 2 Randomized Clinical Trial
16天前
已完结
Recaticimab in adult heterozygous familial hypercholesterolaemia (REMAIN-3): a multicentre, randomized, double-blind, placebo-controlled Phase 3 study
1个月前
已完结
The sequence of changes in intravascular imaging findings during lipid-lowering therapy and its implication
1个月前
已完结
Indirect comparison of statin–ezetimibe and statin–PCSK9 inhibitor combination therapies for coronary artery plaque regression in acute coronary syndrome
2个月前
已完结
Assessing Children's Blood Pressure—Considerations of Age and Body Size: The Muscatine Study
6个月前
已完结
Antihypertensive Medications and C-Reactive Protein in the Multi-Ethnic Study of Atherosclerosis
7个月前
已关闭
PSCK9 inhibitors reduced early recurrent stroke in patients with symptomatic intracranial atherosclerotic stenosis
7个月前
已完结
Subclinical Coronary Atherosclerosis and Risk for Myocardial Infarction in a Danish Cohort
7个月前
已完结
Comparative Effects of Low-Dose Rosuvastatin, Placebo, and Dietary Supplements on Lipids and Inflammatory Biomarkers
7个月前
已完结
皖公网安备34019202002308